TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Total Assets

Annual figures by fiscal year, from SEC filings.

2012: $7.31M2013: $78.29M2014: $143.28M2015: $295.57M2016: $245.21M2017: $277.83M2018: $143.45M2019: $214.45M2020: $353.26M2021: $381.59M2022: $247.94M2023: $205.80M2024: $343.82M2025: $465.89M$465.89M
2012Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$465.89M+35.5%
2024$343.82M+67.1%
2023$205.80M-17.0%
2022$247.94M-35.0%
2021$381.59M+8.0%
2020$353.26M+64.7%
2019$214.45M+49.5%
2018$143.45M-48.4%
2017$277.83M+13.3%
2016$245.21M-17.0%
2015$295.57M+106.3%
2014$143.28M+83.0%
2013$78.29M+970.7%
2012$7.31M—